Innovative MIS Solutions Provider

EndoSystem (Wuhan) Medical Technology Co.,Ltd is a high-tech enterprise co-founded by dozens of industry veterans proficient in marketing, research and development and enterprise management in the year of 2017, focusing on the R&D, production and sales of the full-line of innovative minimally invasive surgical instruments and supporting consumables.

Relying on its own R&D platform, top technology research and development team and medical expert advisory group, EndoSystem Medical has laid out a series of more than 30 innovative products covering the channel establishment, separation, cutting, suture, ligation, high-frequency electrocoagulation, anastomosis and surgical channel closure in the endoscopic surgery, and is committed to providing one-stop innovative minimally surgical solutions.

EndoSystem Medical has strictly followed the requirements of medical device laws and regulations in the whole process of product design, development, manufacture and distribution, and has established a rigid quality management system and obtained ISO 13485 quality management system certificate issued by British Standards Institution, BSI.

Adhered to the strategy of independent intellectual property rights, independent innovation and independent brand, EndoSystem Medical presently has obtained more than 50 patents in China, has initiated more than 10 US patent applications and has access to several corporate honors from local governmental agencies. With rapid corporate growth and development potential, EndoSystem Medical has successfully completed millions of dollars of series A financing in 2021.

EndoSystem Medical has jointly built an industry-university-research platform with several universities in China, continuously integrated the resources of clinical experts in minimally invasive surgery, combined with industrial design and precision manufacturing, developed high-end instruments for minimally invasive surgery, and helped clinical experts to present their product ideas, such as the national key research and development project, mini-invasive treatment system for hypertrophic cardiomyopathy (HCM).

As the innovative leading enterprise in minimally invasive surgery and cardiac surgery subdivision in China, in the future, EndoSystem Medical will uphold the corporate values of "Integrity, Professionalism, Struggle, and Innovation", deeply cultivate innovative surgical solutions for minimally invasive surgery and cardiac surgery, and is committed to providing high-quality, safe, reliable and innovative treatment solutions for doctors and patients around the world.